Mark J. Holness

3.5k total citations
77 papers, 2.8k citations indexed

About

Mark J. Holness is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, Mark J. Holness has authored 77 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 38 papers in Physiology and 27 papers in Biochemistry. Recurrent topics in Mark J. Holness's work include Adipose Tissue and Metabolism (25 papers), Biochemical Acid Research Studies (22 papers) and Diet and metabolism studies (17 papers). Mark J. Holness is often cited by papers focused on Adipose Tissue and Metabolism (25 papers), Biochemical Acid Research Studies (22 papers) and Diet and metabolism studies (17 papers). Mark J. Holness collaborates with scholars based in United Kingdom, United States and Canada. Mark J. Holness's co-authors include Mary C. Sugden, Karen Bulmer, Paul Caton, Nicholas D. Smith, Geoffrey F. Gibbons, Gemma K. Greenwood, Robert A. Harris, Mohammed Gulrez Zariwala, Karen A. Orfali and Lee G.D. Fryer and has published in prestigious journals such as PLoS ONE, Diabetes and Biochemical Journal.

In The Last Decade

Mark J. Holness

77 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J. Holness United Kingdom 31 1.4k 1.1k 698 451 376 77 2.8k
Mary C. Sugden United Kingdom 32 1.6k 1.1× 1.3k 1.2× 749 1.1× 505 1.1× 417 1.1× 108 3.2k
M C Sugden United Kingdom 28 1.2k 0.8× 1.2k 1.1× 474 0.7× 562 1.2× 307 0.8× 94 2.6k
Carina Prip‐Buus France 34 2.1k 1.5× 776 0.7× 286 0.4× 377 0.8× 325 0.9× 64 3.4k
Edwards A. Park United States 35 1.8k 1.3× 987 0.9× 397 0.6× 639 1.4× 570 1.5× 74 3.2k
Guillermo Zalba Spain 39 1.0k 0.7× 1.6k 1.4× 335 0.5× 348 0.8× 407 1.1× 109 4.1k
Minako Imamura Japan 20 1.2k 0.8× 823 0.7× 379 0.5× 559 1.2× 554 1.5× 41 2.8k
Patrizia Guarini Italy 28 853 0.6× 318 0.3× 378 0.5× 437 1.0× 530 1.4× 79 2.4k
Ana Fortuño Spain 35 851 0.6× 1.2k 1.0× 311 0.4× 313 0.7× 347 0.9× 68 3.2k
Gema Medina‐Gómez Spain 34 1.9k 1.3× 1.5k 1.3× 317 0.5× 423 0.9× 508 1.4× 78 3.8k
Ludmila Kazdová Czechia 30 1.1k 0.8× 1.3k 1.1× 225 0.3× 366 0.8× 754 2.0× 144 3.0k

Countries citing papers authored by Mark J. Holness

Since Specialization
Citations

This map shows the geographic impact of Mark J. Holness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Holness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Holness more than expected).

Fields of papers citing papers by Mark J. Holness

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Holness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Holness. The network helps show where Mark J. Holness may publish in the future.

Co-authorship network of co-authors of Mark J. Holness

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Holness. A scholar is included among the top collaborators of Mark J. Holness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Holness. Mark J. Holness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugden, Mary C. & Mark J. Holness. (2017). Lysophosphatidic acid effects on atherosclerosis and thrombosis. Clinical Lipidology. 1 indexed citations
2.
Sugden, Mary C. & Mark J. Holness. (2017). Management of dyslipidemia in HIV-infected patients. Clinical Lipidology. 1 indexed citations
3.
Sugden, Mary C. & Mark J. Holness. (2011). The pyruvate carboxylase-pyruvate dehydrogenase axis in islet pyruvate metabolism: Going round in circles?. Islets. 3(6). 302–319. 44 indexed citations
4.
Byström, Jonas, Jessica A. Wray, Mary C. Sugden, et al.. (2011). Endogenous Epoxygenases Are Modulators of Monocyte/Macrophage Activity. PLoS ONE. 6(10). e26591–e26591. 71 indexed citations
5.
Sugden, Mary C., Mohammed Gulrez Zariwala, & Mark J. Holness. (2009). PPARs and the orchestration of metabolic fuel selection. Pharmacological Research. 60(3). 141–150. 46 indexed citations
6.
Sugden, Mary C., Paul Caton, & Mark J. Holness. (2009). PPAR control: it's SIRTainly as easy as PGC. Journal of Endocrinology. 204(2). 93–104. 162 indexed citations
7.
Wray, Jessica A., Mary C. Sugden, Darryl C. Zeldin, et al.. (2009). The Epoxygenases CYP2J2 Activates the Nuclear Receptor PPARα In Vitro and In Vivo. PLoS ONE. 4(10). e7421–e7421. 54 indexed citations
8.
Holness, Mark J. & Mary C. Sugden. (2006). Epigenetic regulation of metabolism in children born small for gestational age. Current Opinion in Clinical Nutrition & Metabolic Care. 9(4). 482–488. 37 indexed citations
9.
Smith, Nicholas D., et al.. (2001). Excessive glucocorticoid exposure during late intrauterine development modulates the expression of cardiac uncoupling proteins in adult hypertensive male offspring. Pflügers Archiv - European Journal of Physiology. 442(2). 248–255. 28 indexed citations
10.
Sugden, Mary C., Karen Bulmer, Geoffrey F. Gibbons, & Mark J. Holness. (2001). Role of Peroxisome Proliferator-Activated Receptor-α in the Mechanism Underlying Changes in Renal Pyruvate Dehydrogenase Kinase Isoform 4 Protein Expression in Starvation and after Refeeding. Archives of Biochemistry and Biophysics. 395(2). 246–252. 56 indexed citations
11.
Holness, Mark J.. (1999). The impact of dietary protein restriction on insulin secretion and action. Proceedings of The Nutrition Society. 58(3). 647–653. 6 indexed citations
12.
Sugden, Mary C., et al.. (1999). Substrate interactions in the short- and long-term regulation of renal glucose oxidation. Metabolism. 48(6). 707–715. 16 indexed citations
13.
Holness, Mark J. & Mary C. Sugden. (1998). The impact of genetic hypertension on insulin secretion and glucoregulatory control in vivo. Journal of Hypertension. 16(3). 369–376. 16 indexed citations
14.
Sugden, Mary C., Karen A. Orfali, Lee G.D. Fryer, Mark J. Holness, & David A. Priestman. (1997). Molecular Mechanisms Underlying the Long-term Impact of Dietary Fat to Increase Cardiac Pyruvate Dehydrogenase Kinase: Regulation by Insulin, Cyclic AMP and Pyruvate. Journal of Molecular and Cellular Cardiology. 29(7). 1867–1875. 16 indexed citations
15.
Fryer, Lee G.D., et al.. (1996). Regulation of hepatic pyruvate dehydrogenase kinase by insulin and dietary manipulation in vivo. Studies with the euglycaemic-hyperinsulinaemic clamp. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1316(2). 114–120. 14 indexed citations
16.
17.
Sugden, Mary C., Lee G.D. Fryer, David A. Priestman, Karen A. Orfali, & Mark J. Holness. (1996). Increased hepatic pyruvate dehydrogenase kinase activity in fed hyperthyroid rats: studies in vivo and with cultured hepatocytes. Molecular and Cellular Endocrinology. 119(2). 219–224. 11 indexed citations
18.
Sugden, Mary C. & Mark J. Holness. (1993). Control of muscle pyruvate oxidation during late pregnancy. FEBS Letters. 321(2-3). 121–126. 17 indexed citations
19.
Jones, Bethan S., et al.. (1992). Hepatic pyruvate dehydrogenase kinase activities during the starved-to-fed transition. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1134(2). 164–168. 19 indexed citations
20.
Sugden, Mary C. & Mark J. Holness. (1990). Carbohydrate sparing and storage during the starved to fed transition. Biochemical Society Transactions. 18(5). 847–850. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026